Nephrotoxicity With Vancomycin in the Pediatric Population
- 1 July 2018
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 37 (7) , 654-661
Abstract
Background: Vancomycin is frequently used to treat methicillin-resistant Staphylococcus aureus infections in pediatric patients. Vancomycin exposure may lead to an increase in frequency of nephrotoxicity. Our aim was to conduct a systematic review to describe predictors of nephrotoxicity associated with vancomycin, including documented trough concentrations ≥15 mg/L. We also aimed to use a meta-analysis to assess the impact of a vancomycin trough ≥15 mg/L on nephrotoxicity. Methods: A literature search was performed using PubMed, Cochrane Library, Embase and Web of Sciences database. We included randomized clinical trials and observational studies evaluating the relationship between vancomycin troughs and nephrotoxicity in pediatric-age patients. Studies not measuring troughs or defining a different cut-off point than 15 mg/L were excluded. Data on age, exclusion criteria, nephrotoxicity definition, risk factors for nephrotoxicity and vancomycin trough levels were extracted from selected papers. Results: Ten studies were identified for meta-analysis. All subjects had comparatively normal baseline serum creatinine values. Common risk factors identified included elevated (≥15 mg/L) trough levels, renal impairment, hypovolemia and concurrent use of nephrotoxic medications. Troughs ≥15 mg/L increased nephrotoxicity by 2.7-fold (odds ratio (OR), 2.71; 95% confidence interval: 1.82–4.05; I 2 = 40%; Q = 0.09). These odds were further increased among patients in the pediatric intensive care unit (OR, 3.61; 95% confidence interval: 1.21–10.74; I 2 = 45%; Q = 0.18). Conclusions: Though the rate of vancomycin-induced nephrotoxicity is increased in pediatric patients with higher vancomycin troughs, other factors such as intensive care unit admission, hypovolemia and concurrent nephrotoxic drug use appear to contribute to the development of nephrotoxicity.Keywords
This publication has 38 references indexed in Scilit:
- Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-resistant Staphylococcal InfectionsThe Pediatric Infectious Disease Journal, 2013
- Improved Vancomycin Dosing in Children Using Area Under the Curve ExposureThe Pediatric Infectious Disease Journal, 2013
- Acute Kidney Injury During Vancomycin Therapy in Critically Ill ChildrenPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Incidence and Risk Factors Influencing the Development of Vancomycin Nephrotoxicity in ChildrenThe Journal of Pediatrics, 2011
- Risk factors for renal failure in pediatric patients with acute myeloid leukemia: A retrospective cohort studyPediatric Blood & Cancer, 2010
- Use of Vancomycin in PediatricsThe Pediatric Infectious Disease Journal, 2010
- Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulationClinical Therapeutics, 2010
- 15 January NewsClinical Infectious Diseases, 2006
- Vancomycin: A HistoryClinical Infectious Diseases, 2006
- Investigation of Aminoglycoside Nephrotoxicity in Cystic Fibrosis PatientsScandinavian Journal of Gastroenterology, 1988